Analyzing the effectiveness of vaginal misoprostol tablet in ease of performing hysteroscopy and prevention of the adverse events while performing hysteroscopy
Not Applicable
- Conditions
- Health Condition 1: N920- Excessive and frequent menstruation with regular cycleHealth Condition 2: N979- Female infertility, unspecified
- Registration Number
- CTRI/2023/09/057503
- Lead Sponsor
- Dr Chandramma Dayananda Sagar institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All women undergoing diagnostic and operative hysteroscopy
Exclusion Criteria
Refusal for consent, suspected genital malignancy, uncontrolled bleeding per vaginum, active genital infection, allergic to misoprostol & betadine, previous cervical surgeries, mullerian anomalies of the uterus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method